Prevalence and Clinical Relevance of Autoimmune Neutropenia in Patients with Primary Sjögren's Syndrome

Seminars in Arthritis and Rheumatism

Volumn 38, Issue 5, 2009, Pages 389-395

  Brito Zerón, Pilar ^a   Soria, Natalia ^a   Muñoz, Sandra ^a   Bové, Albert ^a   Akasbi, Miriam ^a   Belenguer, Rafael ^a   Sisó, Antoni ^a,b   Ramos Casals, Manuel ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b Centre d'Assistència Primària ABS Les Corts   (Spain)

Author keywords

infections; lymphoma; neutropenia; Sj gren's syndrome

Indexed keywords

COMPLEMENT COMPONENT C4 BINDING PROTEIN; LA ANTIBODY; RHEUMATOID FACTOR; RO ANTIBODY;

ADOLESCENT; ADULT; AGE; AGED; AGRANULOCYTOSIS; ARTICLE; DEATH; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; NEOPLASM; NEUTROPENIA; PREVALENCE; PRIORITY JOURNAL; SJOEGREN SYNDROME; SYSTEMIC DISEASE; T CELL LEUKEMIA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INFECTION; LEUKEMIA, T-CELL; LYMPHOMA; MALE; MIDDLE AGED; NEUTROPENIA; PREVALENCE; SJOGREN'S SYNDROME; YOUNG ADULT;

EID: 62849128421     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2008.01.014     Document Type: Article

References (33)

1. Fox R.I. Sjogren's syndrome. Lancet 366 (2005) 321-331
2. Kassan S.S., and Moutsopoulos H.M. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med 164 (2004) 1275-1284
3. Ramos-Casals M., Tzioufas A.G., and Font J. Primary Sjogren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis 64 (2005) 347-354
4. Ramos-Casals M., and Font J. Primary Sjogren's syndrome: current and emergent aetiopathogenic concepts. Rheumatology (Oxford) 44 (2005) 1354-1367
5. Bloch K.J., Buchanan W.W., Wohl M.J., and Bunim J.J. Sjögren's syndrome. A clinical, pathological and serological study of sixty-two cases. Medicine (Baltimore) 44 (1965) 187-228
6. Skopouli F., Dafni U., Ionnidis J., and Moutsopoulus H.M. Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome. Semin Arthritis Rheum 29 (2000) 296-304
7. Ramos-Casals M., Font J., Garcia-Carrasco M., Brito M.P., Rosas J., Calvo-Alen J., et al. Primary Sjogren syndrome: hematologic patterns of disease expression. Medicine (Baltimore) 81 (2002) 281-292
8. Gottenberg J.E., Busson M., Loiseau P., Cohen-Solal J., Lepage V., Charron D., et al. In primary Sjogren's syndrome. HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum 48 (2003) 2240-2245
9. Martinez-Banos D., Crispin J.C., Lazo-Langner A., and Sanchez-Guerrero J. Moderate and severe neutropenia in patients with systemic lupus erythematosus. Rheumatology (Oxford) 45 (2006) 994-998
10. Vitali C., Bombardieri S., Moutsopoulos H.M., Balestrieri G., Bencivelli W., Bernstein R.M., et al., European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 36 (1993) 340-347
11. Garcia-Carrasco M., Ramos-Casals M., Rosas J., Pallarés L., Calvo-Alen J., Cervera R., et al. Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore) 81 (2002) 270-280
12. Capsoni F., Sarzi-Puttini P., and Zanella A. Primary and secondary autoimmune neutropenia. Arthritis Res Ther 7 (2005) 208-214
13. Trejo O., Ramos-Casals M., Garcia-Carrasco M., Yagüe J., Jiménez S., de la Red G., et al. Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 80 (2001) 252-262
14. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40 (1997) 1725
15. Coppo P., Sibilia J., Maloisel F., Schlageter M.H., Voyer A.L., Gouilleux-Gruart V., et al. Primary Sjogren's syndrome associated agranulocytosis: a benign disorder?. Ann Rheum Dis 62 (2003) 476-478
16. Friedman J., Klepfish A., Miller E.B., Ognenovski V., Ike R.W., and Schattner A. Agranulocytosis in Sjogren's syndrome: two case reports and analysis of 11 additional reported cases. Semin Arthritis Rheum 31 (2002) 338-345
17. Friedman J., Schattner A., Shvidel L., and Berrebi A. Characterization of T-cell large granular lymphocyte leukemia associated with Sjogren's syndrome-an important but under-recognized association. Semin Arthritis Rheum 35 (2006) 306-311
18. Addas-Carvalho M., de Paula E.V., Lima C.S., and Saad S.T. Polymorphisms of interleukin-1 gene complex. IL6 and tumour necrosis factor genes in chronic idiopathic neutropenia of adults. Ann Hematol 84 (2005) 709-714
19. Gavrikova N., Zeidler C., Stanulla M., Germeshausen M., Schwinzer B., and Welte K. TNF and lymphotoxin-alpha polymorphisms in patients with severe chronic neutropenia. Int J Hematol 74 (2001) 477-478
20. Neth O.W., Bajaj-Elliott M., Turner M.W., and Klein N.J. Susceptibility to infection in patients with neutropenia: the role of the innate immune system. Br J Haematol 129 (2005) 713-722
21. Alexander E., Arnett F., Provost T., and Stevens M.B. Sjogren's Syndrome: association of Anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperactivity. Ann Intern Med 98 (1983) 155-159
22. Davidson B.K.S., Kelly C.A., and Griffiths I.D. Primary Sjögren's syndrome in the North East of England: a long-term follow-up study. Rheumatology (Oxford) 38 (1999) 245-253
23. Harley J.B., Alexander E.L., Bias W.B., Fox O.F., Provost T.T., Reichlin M., et al. Anti-Ro(SS-A) and anti-La(SS-B) in patients with Sjogren's syndrome. Arthritis Rheum 29 (1986) 196-206
24. Aoki A., Ohno S., and Ueda A. Hematological abnormalities of primary Sjogren's syndrome. Nihon Rinsho Meneki Gakkai Kaishi 23 (2000) 124-128
25. Baboonian C., Venables P.J.W., Booth J., Williams D.G., Roffe L.M., and Maini R.N. Virus infection induces redistribution and membrane localisation of the nuclear antigen La (SSB): a possible mechanism for autoimmunity. Clin Exp Immunol 78 (1989) 454-459
26. LeFeber W.P., Norris D.A., Ryan S.R., Huff J.C., Lee L.A., Kubo M., et al. Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes. J Clin Invest 74 (1984) 1545-1551
27. Ramos-Casals M., Cervera R., Garcia-Carrasco M., Vidal J., Trejo O., Jiménez S., et al. Cytopenia and past human parvovirus B19 infection in patients with primary Sjogren's syndrome. Semin Arthritis Rheum 29 (2000) 373-378
28. Ramos-Casals M., Loustaud-Ratti V., De Vita S., Zeher M., Bosch J.A., Toussirot E., et al., SS-HCV Study Group. Sjogren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore) 84 (2005) 81-89
29. Lamy T., Dauriac C., Morice P., and Le Prisé P.Y. Agranulocytosis and connectivitis different from Felty's syndrome: 4 cases. Success of cyclosporin in a case. Rev Med Interne 11 (1990) 325-328
30. Maheshwari A., Christensen R.D., and Calhoun D.A. Immune-mediated neutropenia in the neonate. Acta Pediatr 438 (2002) 98-103
31. Shastri K.A., and Logue G.L. Autoimmune neutropenia. Blood 81 (1993) 1984-1995
32. Bux J., Behrens G., Jaeger G., and Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 91 (1998) 181-186
33. Vivancos J., Vila M., Serra A., Loscos J., and Anguita A. Failure of G-CSF therapy in neutropenia associated with Sjogren's syndrome. Rheumatology (Oxford) 41 (2002) 471-473